These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23285908)

  • 1. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].
    Wang D; Du XX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
    Jiang JJ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection].
    Wang LX; Xie YM; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chinese medicine adverse reactions' literature statistical analysis in recent five years].
    Xiang F; Zhang X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2755-8. PubMed ID: 22242443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].
    Zhang L; Yang XH; Cao LY; Ji S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):581-4. PubMed ID: 16089130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical outcomes research of traditional Chinese medicine--introduce registry intensive hospital monitoring study protocol of traditiona Chinese medicine injection's safety].
    Yang W; Xie YM; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2683-5. PubMed ID: 23285907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Using barcode in safety monitoring of traditional Chinese medicines injection].
    Wang ZF; Zhang DZ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2705-6. PubMed ID: 23285914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [To strengthen the monitoring and research on clinical adverse drug reaction induced by Chinese medicines].
    Chen K
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1091. PubMed ID: 11766603
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research and implementation of adverse reaction automatic warning algorithm on Chinese medicine injection].
    Zhuang Y; Xie BT; Xie YM; Weng SX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2695-7. PubMed ID: 23285911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
    Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica.
    Bian ZX; Tian HY; Gao L; Shang HC; Wu TX; Li YP; Zhang BL; Song L
    J Evid Based Med; 2010 Feb; 3(1):5-10. PubMed ID: 21349034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of re-evaluation and development of Chinese herbal drugs].
    Gao Y; Ma Z; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
    Xie Y; Tian F
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Probing into objectivity of adverse drug reaction of traditional Chinese medicine].
    Sun YQ; Ma YG; Xing XY; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2006 Aug; 31(16):1381-3. PubMed ID: 17061563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exploration of how to formulate guidelines on post-marketing traditional Chinese medicine surveillance].
    Zhang W; Xie YM; Yu WY
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2943-8. PubMed ID: 24471309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety research in Chinese medicines based on application of data mining].
    Tong Y; Yang J; Li C; He W
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analyze causes of adverse reactions induced by traditional Chinese medicine injections from its quality standards].
    Cui HY; Liang AH
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):934-40. PubMed ID: 25204194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.